Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Arterial Disease: early-phase trial registry
35 of 80 indexed Peripheral Arterial Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #173 of 28,707 conditions by registered trial count.
80 US clinical trials · 35 currently recruiting · #173 of 28,707 conditions by registered trial count
Peripheral Arterial Disease: 80 US clinical trials tracked, 35 recruiting.
Peripheral Arterial Disease is the subject of 80 registered US clinical trials on ClinicalTrials.gov, 35 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most active sponsor is University of Nebraska, running 7 of these trials.
Enrollment posture brief
Registry condition peripheral-arterial-disease
OPEN 35 | RECR 44% | LATE 7 | EARLY 14 | RANK #173 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Distress Syndrome (44% recruiting · 32 trials)
Peripheral Arterial Disease lists 35 open slots (44% of 80 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Arterial Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Arterial Disease is recruiting above its size-band peers.
35 of 80 indexed trials (43.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Peripheral Arterial Disease trials is spread across many organizations.
University of Nebraska accounts for 7 of 80 trials (8.8%). 56 distinct sponsors appear on at least one study for this condition label.
-
Typical Peripheral Arterial Disease enrolment sits around 100 participants.
Median target enrolment is 100 among the 80 trials that report a genuine target (sentinel values excluded). 40 of those (50%) plan for fewer than 100 participants.
-
Peripheral Arterial Disease research is mostly interventional.
62 interventional and 18 observational studies make up this index (77.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
80 total, page 2 of 2
Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD)
University of Kansas Medical Center
NCT01321086
Validation of a Novel Oscillometric-Based Algorithm for Determination of the Ankle-Brachial Index
Summit Doppler Systems
NCT01165437
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
ReFlow Medical
NCT05358353
Implementation of Telemedicine for Patient With Lower Extremity Wounds
University of California, Davis
NCT04440839
The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
Horizons International Peripheral Group
NCT02464501
EverFlex Post Approval Study
Medtronic Endovascular
NCT01680835
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages
Ra Medical Systems
NCT04241224
Distributed Registry
Stanford University
NCT03898570
Use of Ixmyelocel-T (Formerly Vascular Repair Cells [VRC]) in Patients With Peripheral Arterial Disease to Treat Critical Limb Ischemia
Vericel Corporation
NCT00468000
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
Spectranetics Corporation
NCT03306199
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
Indiana University
NCT02685098
Pilot Study to Determine the Optimal Technique for Measurement of Ankle Blood Pressures
Summit Doppler Systems
NCT00819598
The Jetstream G3™ Calcium Study
Boston Scientific Corporation
NCT01273623
VasoStat vs. TR Band for Radial Hemostasis
Forge Medical
NCT04163471
Nitrites, Exercise, and Peripheral Arterial Disease
Duke University
NCT01684930
Local Paclitaxel Delivery for SFA Disease
University of Oklahoma
NCT00821028
Ischemic Preconditioning Claudication Study
Medical College of Wisconsin
NCT03511157
Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization
University of California, San Francisco
NCT01507558
Cardiac Rehabilitation Program in Peripheral Arterial Disease
University of Kansas Medical Center
NCT03251391
ALD-301 for Critical Limb Ischemia, Randomized Trial
Aldagen
NCT00392509
Endothelial Function in Lower Extremity Bypass Grafts
Brigham and Women's Hospital
NCT00759707
Exercise and Weight Loss in PAD
VA Office of Research and Development
NCT02607033
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
Celularity Incorporated
NCT01859117
Drug Eluting Stent for the Management of PERipheral Arterial Disease Of the SFA (DESPERADO-SFA Study)
Arkansas Heart Hospital
NCT02734836
Feasibility Study to Evaluate Therapeutic Ultrasound (TUS) to Acutely Increase the Perfusion in Peripheral Arterial Disease (PAD)
Vibrato Medical
NCT05888740
Dietary Nitrate Supplementation and Thermoregulation
University of Nebraska
NCT03506646
Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD
Arkansas Heart Hospital
NCT02756884
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
Alucent Biomedical
NCT04188262
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
University of California, San Francisco
NCT02096757
BOLD MRI as a Surrogate of Improved Muscle Oxygenation Following Endovascular Therapy for the Treatment of CLI
Zimmer Biomet
NCT02601430
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 9 |
| Phase 2 | 5 |
| Phase 3 | 3 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Arterial Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Arterial Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Arterial Disease page
80 registered trials, 35 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 35 Peripheral Arterial Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Nebraska sponsors the most Peripheral Arterial Disease trials on record, review their full trial history before evaluating a specific study. See University of Nebraska's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Arterial Disease condition card totals 80 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.